[Congressional Record Volume 168, Number 109 (Tuesday, June 28, 2022)]
[Daily Digest]
[Pages D714-D715]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

Committee Meetings
EXAMINING THE POLICIES AND PRIORITIES OF THE BUREAU OF INDIAN EDUCATION
Committee on Education and Labor: Subcommittee on Early Childhood, 
Elementary, and Secondary Education; and the Subcommittee for 
Indigenous Peoples of the United States of the House Committee on 
Natural Resources held a joint hearing entitled ``Examining the 
Policies and Priorities of the Bureau of Indian Education''. Testimony 
was heard from Beth Sirois, Assistant Director, Education, Workforce, 
and Income Security, Government Accountability Office; and Tony 
Dearman, Director, Bureau of Indian Education.
PROTECTING AMERICA'S SENIORS: OVERSIGHT OF PRIVATE SECTOR MEDICARE 
ADVANTAGE PLANS
Committee on Energy and Commerce: Subcommittee on Oversight and 
Investigations held a hearing entitled ``Protecting America's Seniors: 
Oversight of Private Sector Medicare Advantage Plans''. Testimony was 
heard from Erin Bliss, Assistant Inspector General, Office of 
Evaluation and Inspection, Office of Inspector General, Department of 
Health and Human Services; Leslie Gordon, Acting Director, Health Care, 
Government Accountability Office; and James E. Mathews, Executive 
Director, Medicare Payment Advisory Commission.

[[Page D715]]


WHERE HAVE ALL THE HOUSES GONE? PRIVATE EQUITY, SINGLE FAMILY RENTALS, 
AND AMERICA'S NEIGHBORHOODS
Committee on Financial Services: Subcommittee on Oversight and 
Investigations held a hearing entitled ``Where Have All the Houses 
Gone? Private Equity, Single Family Rentals, and America's 
Neighborhoods''. Testimony was heard from public witnesses.
EXAMINING THE 2022 NATIONAL DRUG CONTROL STRATEGY AND THE FEDERAL 
RESPONSE TO THE OVERDOSE CRISIS
Committee on Oversight and Reform: On June 27, 2022, Full Committee 
held a hearing entitled ``Examining the 2022 National Drug Control 
Strategy and the Federal Response to the Overdose Crisis''. Testimony 
was heard from Rahul Gupta, M.D., Director, Office of National Drug 
Control Policy, Executive Office of the President.
JANUARY 6TH INVESTIGATION
Select Committee to Investigate the January 6th Attack on the United 
States Capitol: Full Committee held a hearing entitled ``January 6th 
Investigation''. Testimony was heard from a public witness.

Joint Meetings
  No joint committee meetings were held.